IFNG and colitis: Simultaneously, the authors also discovered a lowered circulating level of pro-inflammatory IL-1β, IL-6, and IL-17α, along with an increased level of anti-inflammatory IL-12, IFNγ, and IL-10 in the context of colitis-associated cancer, suggesting ameliorated systemic inflammation [149].